Jeff Kutok – Biography
Last update: April 9, 2026Executive profile
Jeff was Chief Scientific Officer at Epizyme, and Chief Scientific Officer at Infinity Pharmaceuticals. Jeff Kutok joined Ensem Therapeutics in 2024.
Jeff Kutok is currentlyChief Scientific Officer at Ensem Therapeutics - View - Ensem Therapeutics org chart
Create your alert
to follow the career of Jeff Kutok.
Education
Jeff Kutok has a PhD in Molecular and Cellular Pathology from State University of New York at Stony Brook.
They have also studied at State University of New York at Stony Brook :
Find more alumni from State University of New York at Stony Brook
More about Jeff Kutok
Selected links
Do you need to know more about Jeff Kutok? More results.
Participate
Social media
- Jeff Kutok on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Jeff Kutok
The colleagues of Jeff Kutok
Company Colleagues
- At Ensem Therapeutics, Jeff Kutok has 10 colleagues including Shenfang Jin (CEO & Director), Sean Cao (Director)…
Industry Colleagues
- In the Biotechnology industry, Jeff Kutok has 35,756 colleagues in 2,406 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Get in Touch
Here are a few tips for establishing great contacts.
